Lancet Commission: Stem cells and regenerative medicine. (2018)
Attributed to:
RegenVOX: phase I/II clinical trial of stem cell based tissue engineered laryngeal implants
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(17)31366-1
PubMed Identifier: 28987452
Publication URI: http://europepmc.org/abstract/MED/28987452
Type: Journal Article/Review
Volume: 391
Parent Publication: Lancet (London, England)
Issue: 10123
ISSN: 0140-6736